Kenvue Inc. (KVUE)
Kenvue Inc. (KVUE) All Metrics
KVUE Valuation Metrics
KVUE Stock Price Metrics
Last Close Price$18.411-Day Change+3.08%Market Cap (USD)$35.347B7D Return2.22%30D Return5.02%YTD Return6.29%52-Week High$22.8752-Week High Date07/25/2025Current vs High(19.50%)52-Week Low$14.0252-Week Low Date10/16/2025Current vs Low31.31%Avg Volume 1M19.509MBeta0.50Fair Value Price$30.50Margin of Safety65.68%
KVUE Dividend Metrics
Dividend Yield4.51%Avg Yield TTM4.51%Avg Yield 3Y3.68%CAGR TTM1.85%CAGR 3Y-CAGR 5Y-Payout Ratio107.79%Payout Avg 3Y100.53%Payout Avg 5Y-FCF Payout Ratio87.28%FCF Payout Avg 3Y78.48%FCF Payout Avg 5Y-Forward YOC 3Y-Forward YOC 5Y-Forward YOC 10Y-Ex-Date05/13/2026Payment Date05/27/2026Consec. Yearly Increases2
KVUE Growth Rate Metrics
Price CAGR TTM(13.86%)Price CAGR 3Y(11.41%)Price CAGR 5Y-Total Return CAGR TTM(9.89%)Total Return CAGR 3Y(7.76%)Total Return CAGR 5Y-Revenue CAGR TTM(0.07%)Revenue CAGR 3Y0.74%Revenue CAGR 5Y0.91%Net Income CAGR TTM53.60%Net Income CAGR 3Y(7.38%)Net Income CAGR 5Y0.40%EPS CAGR TTM(7.53%)EPS CAGR 3Y(8.55%)EPS CAGR 5Y0.22%FCF CAGR TTM25.72%FCF CAGR 3Y(4.97%)FCF CAGR 5Y(7.28%)Dividends CAGR TTM1.85%Dividends CAGR 3Y-Dividends CAGR 5Y-
KVUE Discounted Cash Flow Metrics
| Fair Value Price | $30.50 |
| Margin of Safety | 65.68% |
KVUE Revenue Metrics
KVUE PE Ratio Metrics
| PE Ratio | 21.66 |
| PE Ratio Avg TTM | 22.84 |
| PE Ratio Avg 3Y | 28.59 |
| Current VS TTM Avg | -5.15% |
| Current VS 3Y Avg | -24.25% |
| Current VS 5Y Avg | -23.58% |
KVUE PS Ratio Metrics
| PS Ratio | 2.31 |
| PS Ratio Avg TTM | 2.25 |
| PS Ratio Avg 3Y | 2.54 |
| Current VS TTM Avg | +2.81% |
| Current VS 3Y Avg | -9.06% |
| Current VS 5Y Avg | -9.68% |
KVUE PB Ratio Metrics
| PB Ratio | 3.34 |
| PB Ratio Avg TTM | 3.14 |
| PB Ratio Avg 3Y | 3.64 |
| Current VS TTM Avg | +6.32% |
| Current VS 3Y Avg | -8.24% |
| Current VS 5Y Avg | -8.24% |
KVUE Price to Free Cash Flow Ratio Metrics
| PFCF Ratio | 19.41 |
| PFCF Ratio Avg TTM | 19.98 |
| PFCF Ratio Avg 3Y | 21.58 |
| Current VS TTM Avg | -2.86% |
| Current VS 3Y Avg | -10.04% |
| Current VS 5Y Avg | -9.25% |
KVUE Debt to Equity Ratio Metrics
| Debt/Equity Ratio | 0.79 |
| Debt/Equity Ratio Avg TTM | 0.84 |
| Debt/Equity Ratio Avg 3Y | 0.72 |
| Current VS TTM Avg | -6.51% |
| Current VS 3Y Avg | +9.34% |
| Current VS 5Y Avg | +63.45% |
KVUE PEG Ratio Metrics
| PEG Ratio | 0.52 |
| PEG Ratio Avg TTM | - |
| PEG Ratio Avg 3Y | - |
| Current VS TTM Avg | - |
| Current VS 3Y Avg | - |
| Current VS 5Y Avg | +19.54% |
KVUE FCF Yield
| FCF Yield | 5.15% |
| FCF Yield Avg TTM | 5.01% |
| FCF Yield Avg 3Y | 5.01% |
| Current VS TTM Avg | +2.88% |
| Current VS 3Y Avg | +2.82% |
| Current VS 5Y Avg | +2.11% |
KVUE Earnings Yield
| Earnings Yield | 4.62% |
| Earnings Yield Avg TTM | 4.38% |
| Earnings Yield Avg 3Y | 3.79% |
| Current VS TTM Avg | +5.42% |
| Current VS 3Y Avg | +21.78% |
| Current VS 5Y Avg | +20.97% |
KVUE EV/EBIT Ratio Metrics
| Ev/Ebit Ratio | 14.32 |
| Ev/Ebit Ratio Avg TTM | 16.47 |
| Ev/Ebit Ratio Avg 3Y | 20.64 |
| Current VS TTM Avg | -13.05% |
| Current VS 3Y Avg | -30.63% |
| Current VS 5Y Avg | -30.14% |
KVUE EV/EBITDA Ratio Metrics
| Ev/Ebitda Ratio | 13.56 |
| Ev/Ebitda Ratio Avg TTM | 13.83 |
| Ev/Ebitda Ratio Avg 3Y | 16.28 |
| Current VS TTM Avg | -1.99% |
| Current VS 3Y Avg | -16.71% |
| Current VS 5Y Avg | -16.55% |
KVUE EV/Assets Ratio Metrics
| Ev/Assets Ratio | 1.60 |
| Ev/Assets Ratio Avg TTM | 1.53 |
| Ev/Assets Ratio Avg 3Y | 1.71 |
| Current VS TTM Avg | +4.81% |
| Current VS 3Y Avg | -6.37% |
| Current VS 5Y Avg | -6.37% |
KVUE EV/Sales Ratio Metrics
| Ev/Sales Ratio | 2.81 |
| Ev/Sales Ratio Avg TTM | 2.78 |
| Ev/Sales Ratio Avg 3Y | 3.04 |
| Current VS TTM Avg | +1.18% |
| Current VS 3Y Avg | -7.44% |
| Current VS 5Y Avg | -7.85% |
KVUE Current Ratio Metrics
| Current Ratio | 0.96 |
| Current Ratio Avg TTM | 0.96 |
| Current Ratio Avg 3Y | 1.14 |
| Current VS TTM Avg | 0.00% |
| Current VS 3Y Avg | -15.42% |
| Current VS 5Y Avg | -9.58% |
KVUE Quick Ratio Metrics
| Quick Ratio | 0.68 |
| Quick Ratio Avg TTM | 0.69 |
| Quick Ratio Avg 3Y | 0.77 |
| Current VS TTM Avg | -0.73% |
| Current VS 3Y Avg | -11.69% |
| Current VS 5Y Avg | -4.45% |
KVUE ROIC Metrics
| ROIC | 8.80% |
| ROIC Avg 3Y | 8.07% |
| ROIC Avg 5Y | 6.17% |
| Current VS 3Y Avg | +9.05% |
| Current VS 5Y Avg | +42.55% |
| Current VS 10Y Avg | +66.31% |
KVUE Return on Assets Metrics
| ROA | 5.43 |
| ROA Avg TTM | 4.72 |
| ROA Avg 3Y | 5.74 |
| Current VS TTM Avg | +14.92% |
| Current VS 3Y Avg | -5.48% |
| Current VS 5Y Avg | +18.86% |
KVUE Return on Equity Metrics
| ROE | 13.66 |
| ROE Avg TTM | 12.16 |
| ROE Avg 3Y | 12.37 |
| Current VS TTM Avg | +12.38% |
| Current VS 3Y Avg | +10.41% |
| Current VS 5Y Avg | +49.32% |
KVUE Net Profit Margin Metrics
| Net Profit Margin | 9.72% |
| Net Profit Margin Avg TTM | 8.19% |
| Net Profit Margin Avg 3Y | 10.24% |
| Current VS TTM Avg | +18.68% |
| Current VS 3Y Avg | -5.08% |
| Current VS 5Y Avg | +19.80% |
Last Updated: Wednesday, June 24, 2026
About Kenvue Inc.
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- CEO
- Kirk L. Perry